Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Sumedha V. Chablani
Claudia Ramos-Rivers
David G. Binion
Eva Szigethy
机构：
[1] UPMC Montefiore Hospital,Department of Medicine
[2] UPMC Presbyterian Hospital M2,Division of Gastroenterology, Hepatology and Nutrition
[3] Visceral Inflammation and Pain (VIP) Center,Division of Gastroenterology, Hepatology and Nutrition
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2482 / 2484
页数：2
相关论文
共 50 条
  • [1] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease
    Chablani, Sumedha V.
    Ramos-Rivers, Claudia
    Binion, David G.
    Szigethy, Eva
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (09) : 2482 - 2484
  • [2] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567
  • [3] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [4] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [5] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [6] Psoriasis Associated With Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Cullen, Garret
    Kroshinsky, Daniela
    Cheifetz, Adam S.
    Korzenik, Joshua R.
    GASTROENTEROLOGY, 2011, 140 (05) : S774 - S775
  • [7] Should patients with inflammatory bowel disease and depression be given anti-tumor necrosis factor therapy?
    Barnes, A.
    Mountifield, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 130 - 130
  • [8] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Androulakis, Ioannis
    Zavos, Christos
    Christopoulos, Panagiotis
    Mastorakos, George
    Gazouli, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13205 - 13211
  • [9] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [10] Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
    Bortlik, Martin
    Duricova, Dana
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Malickova, Karin
    Kolar, Martin
    Lukas, Milan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (02) : 196 - 202
12345